2-[(4-Chloronaphthalen-1-yl)oxy]acetic acid → HCID 131715126, Verbindung
Reaktionsgleichung
[CH3:1][N:2]([CH3:11])[C@@H:3]1[CH2:8][CH2:7][CH2:6][CH2:5][C@H:4]1[NH:9][CH3:10].[Cl:12][C:13]1[C:22]2[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=2)[C:16]([O:23][CH2:24][C:25]([OH:27])=O)=[CH:15][CH:14]=1>>[ClH:12].[Cl:12][C:13]1[C:22]2[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=2)[C:16]([O:23][CH2:24][C:25]([N:9]([C@@H:4]2[CH2:5][CH2:6][CH2:7][CH2:8][C@H:3]2[N:2]([CH3:1])[CH3:11])[CH3:10])=[O:27])=[CH:15][CH:14]=1Komponenten
3
Versuchsvorschrift
Starting with trans-2-dimethylamino-N-methylcyclohexanamine and [(4-chloro-1-naphthalenyl)oxy]acetic acid, the title compound, m.p. 135°-138° C., was prepared employing the method of Example 5.
Quellen und Nachweise
- ORD-Eintrag
- ord-62a4a2c31bf745dc943dfc4390e2bd93
- Quelldatensatz
- uspto-grants-1987_05
- Patentnummer